HANRISVA

Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, blood, and diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines, human vaccine preparations; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections.